NCT04530422View on ClinicalTrials.gov

Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment

PHASE3CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

July 8, 2020

Study Completion Date

July 23, 2020

Conditions

Covid19

Interventions

DRUG

Sofosbuvir plus Ledipasvir

"Sofosbuvir plus Ledipasvir, once daily for 15 to 21days~* Oseltamivir 150 mg q 12 hours for 10 days ;~* HCQ 400 q 12 hours for one day followed by 200mg q 12 hours for 9 days ; and~* Azithromycin 500mg once daily for 1 day , followed by 250mg once daily for 6 days."

Trial Locations (1)

Unknown

Almaza Military Fever Hospital, Cairo

All Listed Sponsors

lead

Almaza Military Fever Hospital

OTHER

NCT04530422 - Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment | Biotech Hunter | Biotech Hunter